Page last updated: 2024-09-04

naproxen and Carcinoma 256, Walker

naproxen has been researched along with Carcinoma 256, Walker in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curi, R; Fabrício, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E1
Aikawa, J; Bonato, SJ; Curi, R; de Oliveira, HH; Facin, M; Fernandes, LC; Fernandez, R; Ferraz, AC; Folador, A; Grohs, H; Naliwaiko, K; Nishiyama, A; Pinto, JA; Pizato, N; Yamazaki, RK1

Other Studies

2 other study(ies) available for naproxen and Carcinoma 256, Walker

ArticleYear
Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats.
    Cancer letters, 2003, Nov-25, Volume: 201, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Eating; Energy Intake; Glycogen; Insulin; Kidney; Liver; Muscle, Skeletal; Naproxen; Rats; Rats, Wistar

2003
Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats.
    The Journal of nutritional biochemistry, 2004, Volume: 15, Issue:6

    Topics: Animals; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Female; Fish Oils; Insulin; Naproxen; Rats; Rats, Wistar

2004